Aguirre Clémentine, ten Brink Tim, Cala Olivier, Guichou Jean-François, Krimm Isabelle
UMR5280 CNRS, Institut des Sciences Analytiques, Ecole Normale Supérieure de Lyon, Université Lyon 1, Villeurbanne, France.
J Biomol NMR. 2014 Nov;60(2-3):147-56. doi: 10.1007/s10858-014-9864-9. Epub 2014 Sep 26.
The fragment-based drug design approach consists of screening libraries of fragment-like ligands, to identify hits that typically bind the protein target with weak affinity (100 μM-5 mM). The determination of the protein-fragment complex 3D structure constitutes a crucial step for uncovering the key interactions responsible for the protein-ligand recognition, and for growing the initial fragment into potent active compounds. The vast majority of fragments are aromatic compounds that induce chemical shift perturbations (CSP) on protein NMR spectra. These experimental CSPs can be quantitatively used to guide the ligand docking, through the comparison between experimental CSPs and CSP back-calculation based on the ring current effect. Here we implemented the CSP back-calculation into the scoring function of the program PLANTS. We compare the results obtained with CSPs measured either on amide or aliphatic protons of the human peroxiredoxin 5. We show that the different kinds of protons lead to different results for resolving the 3D structures of protein-fragment complexes, with the best results obtained with the Hα protons.
基于片段的药物设计方法包括筛选类片段配体库,以识别通常以弱亲和力(100 μM - 5 mM)结合蛋白质靶点的命中物。蛋白质 - 片段复合物三维结构的确定是揭示负责蛋白质 - 配体识别的关键相互作用以及将初始片段扩展为强效活性化合物的关键步骤。绝大多数片段是能在蛋白质核磁共振谱上引起化学位移扰动(CSP)的芳香族化合物。通过比较实验CSP与基于环电流效应的CSP反向计算结果,这些实验CSP可定量用于指导配体对接。在此,我们将CSP反向计算应用于程序PLANTS的评分函数中。我们比较了用人过氧化物还原酶5的酰胺质子或脂肪族质子测得的CSP所获得的结果。我们表明,不同类型的质子在解析蛋白质 - 片段复合物的三维结构时会导致不同的结果,其中用Hα质子获得的结果最佳。